Multimodal cancer therapy involving oncolytic Newcastle Disease Virus, autologous immune cells and bispecific antibodies
This chapter focusses on oncolytic Newcastle disease virus (NDV). It summarizes i) the peculiarities of this virus as an anti-cancer and immune stimulatory agent and ii) approaches to further harness it as a vector to combat cancer. Special emphasis is given on combining virus therapy with cell ther...
Main Authors: | Volker eSchirrmacher, Philippe eFournier |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00224/full |
Similar Items
-
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
by: Philippe Fournier, et al.
Published: (2013-07-01) -
Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
by: Volker Schirrmacher
Published: (2022-02-01) -
Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
by: Volker Schirrmacher, et al.
Published: (2022-10-01) -
Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
by: Volker Schirrmacher, et al.
Published: (2019-08-01) -
Mechanisms of oncolytic activity of Newcastle disease virus strain AF2240 in human renal carcinoma cell line
by: Ch'ng, Wei Choong
Published: (2014)